Evidence map›Paper›PMID 40538737›Full record

ArticlePeerJ2025

Antifungal effects of andrographolide and its combination with amphotericin B against selected fungal pathogens.

Gayus Sale Dafur, Tuan Noorkorina Tuan Kub, Kirnpal Kaur Banga Singh, Azian Harun, Fatmawati Lambuk, Rohimah Mohamud, Ramlah Kadir, Norzila Ismail, Norhayati Yusop

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gayus Sale DafurDepartment of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia.
Tuan Noorkorina Tuan KubDepartment of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia.
Kirnpal Kaur Banga SinghDepartment of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia.
Azian HarunDepartment of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia.
Fatmawati LambukDepartment of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia.
Rohimah MohamudDepartment of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia.
Ramlah KadirDepartment of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia.
Norzila IsmailDepartment of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia.
Norhayati YusopSchool of Dental Sciences, Universiti Sains Malaysia, Kota Bharu, Kelantan, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite advancements in antifungal therapies, the development of resistance to conventional drugs has compromised treatment outcomes, creating an urgent need for novel therapeutic approaches. Andrographolide, a key bioactive compound from

Indexed as

Amphotericin BAntifungal AgentsDiterpenesFungiArthrodermataceaeAspergillusAspergillus fumigatusCandida albicansDrug SynergismHumansMicrobial Sensitivity TestsMicrosporumAmphotericin BandrographolideAntifungal AgentsDiterpenesAmphotericin BAndrographolideAntifungalFungal pathogens

Identifiers

PMID40538737
PMCPMC12178247

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.